Katarzyna Radke

1 – 8 of 8

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/68683a10-4dba-42ea-9773-65c179ce1b7d?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2025
Mark Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma
Mañas, Adriana ^LU ; Seger, Alexandra ^LU ; Adamska, Aleksandra ^LU ; Smyrilli, Kyriaki ^LU ; Siaw, Joachim T. ^LU ; Radke, Katarzyna ^LU ; Muciño-Olmos, Erick A. ^LU ; Bedoya-Reina, Oscar C. ; Esfandyari, Javanshir ^LU and Aaltonen, Kristina ^LU , et al. (2025) In NPJ precision oncology 9. p.1-18
- Contribution to journal › Article
Mark Evolutionary unpredictability in cancer model systems
Chattopadhyay, Subhayan ^LU ; Karlsson, Jenny ^LU ; Ferro, Michele ^LU ; Mañas, Adriana ^LU ; Kanzaki, Ryu ^LU ; Fredlund, Elina ^LU ; Murphy, Andrew J. ; L. Morton, Christopher ; Andersson, Natalie ^LU and A. Woolard, Mary , et al. (2025) In Scientific Reports 15(20334).
- Contribution to journal › Article
2023
Mark Therapeutic strategies for high-risk neuroblastoma
Radke, Katarzyna ^LU (2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
Mark Patient-derived models : Advanced tools for precision medicine in neuroblastoma
Aaltonen, Kristina ^LU ; Radke, Katarzyna ^LU ; Adamska, Aleksandra ^LU ; Seger, Alexandra ^LU ; Mañas, Adriana ^LU and Bexell, Daniel ^LU (2023) In Frontiers in Oncology 12.
- Contribution to journal › Article
2022
Mark Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance
Mañas, Adriana ^LU ; Aaltonen, Kristina ^LU ; Andersson, Natalie ^LU ; Hansson, Karin ^LU ; Adamska, Aleksandra ^LU ; Seger, Alexandra ^LU ; Yasui, Hiroaki ^LU ; van den Bos, Hilda ; Radke, Katarzyna ^LU and Esfandyari, Javanshir ^LU , et al. (2022) In Science Advances 8(43).
- Contribution to journal › Article
2021
Mark Anti-tumor effects of rigosertib in high-risk neuroblastoma
Radke, Katarzyna ^LU ; Hansson, Karin ^LU ; Sjölund, Jonas ^LU ; Wolska, Magdalena ; Karlsson, Jenny ^LU ; Esfandyari, Javanshir ^LU ; Pietras, Kristian ^LU ; Aaltonen, Kristina ^LU ; Gisselsson, David ^LU and Bexell, Daniel ^LU (2021) In Translational Oncology 14(8).
- Contribution to journal › Article
2020
Mark Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma
Hansson, Karin ^LU ; Radke, Katarzyna ^LU ; Aaltonen, Kristina ^LU ; Saarela, Jani ; Mañas, Adriana ^LU ; Sjölund, Jonas ^LU ; Smith, Emma M ^LU ; Pietras, Kristian ^LU ; Påhlman, Sven ^LU and Wennerberg, Krister , et al. (2020) In Science Translational Medicine 12(562).
- Contribution to journal › Article
2019
Mark Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
Mohlin, Sofie ^LU ; Hansson, Karin ^LU ; Radke, Katarzyna ^LU ; Martinez, Sonia ; Blanco-Apiricio, Carmen ; Garcia-Ruiz, Cristian ^LU ; Welinder, Charlotte ^LU ; Esfandyari, Javanshir ^LU ; O'Neill, Michael and Pastor, Joaquin , et al. (2019) In EMBO Molecular Medicine 11(8).
- Contribution to journal › Article